Login
$NBP
$0.79 -$0.06 (6.64%) Live

Ownership

13F as of Q2 2026 · 265.4M shares outstanding

Who owns NBP?

By type of holder
Institutions 9.3% Insiders 0.0% Everyone else 90.7%
Concentration Top 10 holders own 32.2%
Everest Medicines Limited 16.0% · Hillhouse Investment Management, Ltd. 5.0%
Institutional ownership
9.3%
-1.8 pts vs last qtr
Institutional holders
48
0 vs last qtr
Net shares bought
−4.7M
by institutions in Q2 2026
New / sold out
13 / 13
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Marshall Wace, LLP NEW +1.2M
  • Two Sigma Investments, LP NEW +851.3K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −6.0M
  • Point72 Asset Management, L.P. SOLD OUT −1.4M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$648K
6 notices from 3 people
Shares covered
186.9K
0.07% of the company
Arranged in advance
80%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$259.8K$519.6KDec 2025: $14.5K without a planDecJan 2026: $519.6K under a 10b5-1 planJanFebMar 2026: $10.2K without a planMarAprMay 2026: $18.5K without a planMayJunJulAugSep 2026: $85.2K without a planSepOctNov
Largest proposed sellers
  • Skelton Joseph W. Officer 10b5-1 $520K
  • Cao Sean Wuxiong Officer $97.9K

Sign up to see all 3.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2017–FY2025
+3735.5%
+57.75% a year
Each share's claim on the business
−97.4%
shrank without buying or selling a share
Diluted shares, split-adjusted
5.6M114.0M222.5M2017: 5.7M shares'172018: 6.5M shares'182019: 7.4M shares'192020: 157.2M shares'202021: 174.7M shares'212022: 189.8M shares'222023: 191.4M shares'232024: 186.7M shares'242025: 220.3M shares'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years40% 3–5 years2% 1–3 years6% Under 1 year52%
Quarterly turnover
24.8%
of institutional shares changed hands
Top 10 managers, median time held
3 quarters

Super Investors

Investment managers reporting NBP on Form 13F
JH
Janus Henderson Group PLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
HA
HHLR Advisors, LTD.
13D · 4.9%
Shares
6.0M
% of company
2.25%
Change vs last qtr
Unchanged
Held since
≤2021

28 more super investors behind a free account

See every manager holding NovaBridge Biosciences, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting NBP on Form N-PORT; together they hold 0.5% of the company
IB
Position value
$1.15M
% of company
0.22%
% of the fund
0.01%
As of
June 30, 2026
Position value
$581K
% of company
0.11%
% of the fund
0.00%
As of
June 30, 2026

14 more funds behind a free account

See every fund holding NovaBridge Biosciences and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
EM
Everest Medicines Limited
5%+ holder13D · 16.1%
Shares
42.5M
% of company
16.02%
Change vs last qtr
—
Held since
—
HI
Hillhouse Investment Management, Ltd.
5%+ holder13D · 4.9%
Shares
13.3M
% of company
5.01%
Change vs last qtr
—
Held since
—

1 more holders behind a free account

See every insider and 5%+ holder of NovaBridge Biosciences.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support